SCHEMBL8320799

SCHEMBL8320799

CN1CCC(n2cc(-c3ccccc3)c3c(N)ncnc32)CC1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 15/20 0.81
EGFR P00533 13/20 0.78
ABL1 P00519 10/20 0.78
ABL2 P42684 9/20 0.78
RIPK2 O43353 2/20 0.74
LCK P06239 6/20 0.70
TEK Q02763 5/20 0.70
KDR P35968 3/20 0.70
FYN P06241 2/20 0.70
LYN P07948 2/20 0.70
CSK P41240 2/20 0.70
BTK Q06187 2/20 0.70
HCK P08631 2/20 0.70
PLK4 O00444 1/20 0.70
DCLK1 O15075 1/20 0.70
PDPK1 O15530 1/20 0.70
PRKD3 O94806 1/20 0.70
MAP4K4 O95819 1/20 0.70
PAK4 O96013 1/20 0.70
CHEK2 O96017 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20351777 0.91 SRC (0.66) SRCEGFRABL1ABL2RIPK2
SCHEMBL132510 0.88 SRC (1.00) SRCEGFRABL1ABL2RIPK2
SCHEMBL6465399 0.87 LCK (0.89) SRCEGFRABL1LCKTEK
SCHEMBL5936173 0.86 SRC (0.97) SRCEGFRABL1ABL2RIPK2
SCHEMBL8320765 0.86 SRC (0.75) SRCEGFRABL1ABL2RIPK2
SCHEMBL20351637 0.86 SRC (0.65) SRCEGFRABL1ABL2RIPK2
SCHEMBL7020164 0.86 SRC (0.81) SRCEGFRABL1ABL2RIPK2
SCHEMBL8114235 0.85 SRC (0.71) SRCEGFRABL1ABL2RIPK2
Hydrochloric Acid SCHEMBL7098308 0.83 SRC (0.85) SRCEGFRABL1ABL2RIPK2
SCHEMBL23847631 0.83 SRC (0.77) SRCEGFRABL1ABL2RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888353-A1 NOVEL N-7-HETEROCYCLYL PYRROLO 2,3-D]PYRIDINES AND THEIR USE Novartis AG (CH) 1999-01-07 EP disclosed
WO-1997034895-A1 NOVEL N-7-HETEROCYCLYL PYRROLO[2,3-D]PYRIDINES AND THEIR USE NOVARTIS AG (CH) 1997-09-25 WO disclosed